LXRX: Lexicon Corp Stock Quotes

Lexicon Pharmaceuticals (LXRX) focuses on developing targeted therapies for cardiovascular and metabolic pathologies, mitigating risks by transferring sales rights to global counterparties. The stock price history confirms the current trend, where the key indicator stands at 1.78. High profit growth potential is driven by patent ownership, while business development relies on the independent deployment of a sales network without mergers.

Price Performance Chart: lexpharma.com (LXRX) for 07/04/2022 - 11/14/2026

Lexicon Pharma - analytical breakdowns and key metrics (LXRX)

- stock value and consensus price forecast:

Price Chart Lexicon Pharmaceuticals, Inc.|LXRX - Price Target Chart

- market capitalization information:

Market Valuation Lexicon Pharmaceuticals, Inc.|LXRX - Business Value

- issuer book value statistics:

Net Assets per Single Share Lexicon Pharmaceuticals|LXRX - Accounting Value of Company|Market Cap to Net Assets Ratio lexpharma.com|LXRX - Total Business Assets

- business debt structure and liquidity details:

- company profitability and valuation multiples indicators:

LXRX - Net Income|Projected Future Earnings Lexicon Pharmaceuticals|LXRX - P/E Multiple|Projected Price to Earnings Lexicon Pharma|LXRX - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lexicon Pharmaceuticals|LXRX - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Lexicon Pharmaceuticals|LXRX - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months lexpharma.com|LXRX - Net earnings per one share growth for the current year|Earnings growth forecast for next year Lexicon Pharmaceuticals

- sales volume and revenue information:

LXRX - Revenue and Sales Volume|Projected Sales Volume Lexicon Pharmaceuticals, Inc.|LXRX - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Lexicon Pharmaceuticals Inc

Fundamental valuation:lexpharma.com

Signature product of Lexicon Pharmaceuticals Inc

For Lexicon Pharmaceuticals (LXRX), the market value of shares reflects a balance between the potential of new drugs and the risks of insurance payouts or patent conflicts. This indicator aggregates total demand, transforming investor expectations into the current value of the business stake, which allows for the differentiation of fundamental value from market volatility. Analyzing the financial asset's price action helps determine whether the current price is a fair valuation or the result of a temporary market misconception.

Analysis of competing companies